The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis

EuroIntervention

Volumn 8, Issue 5, 2012, Pages 563-570

  Khawaja, Muhammed Zeeshan ^a,b   Thomas, Martyn ^b   Joshi, Abhishek ^b   Asrress, Kaleab N ^a,b   Wilson, Karen ^b   Bolter, Kirsty ^b   Young, Christopher P ^b   Hancock, Jane ^b   Bapat, Vinayak ^b   Redwood, Simon ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute kidney injury; TAVI; Transcatheter aortic valve implantation; VARC

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART VALVE BIOPROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURVIVAL TIME; TIME OF DEATH; TRANSCATHETER AORTIC VALVE IMPLANTATION;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; AORTIC VALVE; BIOPROSTHESIS; CARDIAC CATHETERIZATION; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84870417854     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8I5A87     Document Type: Article

References (44)

1. Bakaeen FG, Chu D, Ratcliffe M, Gopaldas RR, Blaustein AS, Venkat R, Huh J, LeMaire SA, Coselli JS, Carabello BA. Severe aortic stenosis in a veteran population: treatment considerations and survival. Ann Thorac Surg. 2010;89:453-8.
2. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde J-L, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24:1231-43.
3. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med. 2011;364:2187-98.
4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
5. Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O'Neill WW, Davidson CJ, Smith CR, Leon MB, Cohen DJ. Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared with Standard Care Among Inoperable Patients with Severe Aortic Stenosis: Results from The PARTNER Trial (Cohort B). Circulation. 2012;125:1102-9.
6. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry. Circulation. 2011;124:425-33.
7. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve. Circulation. 2010;122:62-9.
8. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr F-W, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69-76.
9. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, de Jaegere P, Fournial G, Kappetein A-P, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Piérard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Segesser Von LK, Walther T, European Association of Cardio-Thoracic Surgery, European Society of Cardiology, European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention. 2008;4:193-9.
10. Mehta RH, Honeycutt E, Patel UD, Lopes RD, Shaw LK, Glower DD, Harrington RA, Califf RM, Sketch MH. Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting. Am J Cardiol. 2010;106:1728-34.
11. Thakar CV, Worley S, Arrigain S, Yared J-P, Paganini EP. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int. 2005;67:1112-9.
12. Elhmidi Y, Bleiziffer S, Piazza N, Hutter A, Opitz A, Hettich I, Kornek M, Ruge H, Brockmann G, Mazzitelli D, Lange R. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J. 2011;161:735-9.
13. Bagur R, Webb JG, Nietlispach F, Dumont E, de LaRochellière R, Doyle D, Masson J-B, Gutiérrez MJ, Clavel M-A, Bertrand OF, Pibarot P, Rodés-Cabau J. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31:865-74.
14. Strauch JT, Scherner MP, Haldenwang PL, Pfister R, Kuhn EW, Madershahian N, Rahmanian P, Wippermann J, Wahlers T. Minimally invasive transapical aortic valve implantation and the risk of acute kidney injury. Ann Thorac Surg. 2010;89:465-70.
15. Aregger F, Wenaweser P, Hellige GJ, Kadner A, Carrel T, Windecker S, Frey FJ. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol. Dial. Transplant. 2009;24:2175-9.
16. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med. 2007;33:409-13.
17. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein A-P, Krucoff MW, Mack M, Mehran R, Miller C, Morel M-A, Petersen J, Popma JJ, Takkenberg JJM, Vahanian A, van Es G-A, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205-17.
18. Thomas M. Trans-catheter aortic valve implantation in the United Kingdom: NICE guidance. Heart. 2008;95:674-5.
19. Grube E, Laborde J-C, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW. Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study. Circulation. 2006;114:1616-24.
20. Ye J, Cheung A, Lichtenstein SV, Pasupati S, Carere RG, Thompson CR, Sinhal A, Webb JG. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg. 2007;31:16-21.
21. Bapat VV, Khawaja MZ, Attia R, Narayanan A, Wilson K, MacGillivray K, Young C, Hancock J, Redwood S, Thomas M. Transaortic transcatheter aortic valve implantation using Edwards SAPIEN valve: a novel approach. Catheter Cardiovasc Interv. 2012;79:733-40.
22. Gummert JF, Bucerius J, Walther T, Doll N, Falk V, Schmitt DV, Mohr FW. Requirement for renal replacement therapy in patients undergoing cardiac surgery. Thorac Cardiovasc Surg. 2004;52:70-6.
23. Bonventre JV. Mediators of Ischemic Renal Injury. Annu. Rev. Med. 1988;39:531-44.
24. Spielman WS, Arend LJ. Adenosine receptors and signaling in the kidney. Hypertension. 1991;17:117-30.
25. Okusa MD. The inflammatory cascade in acute ischemic renal failure. Nephron. 2002;90:133-8.
26. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000;109:665-78.
27. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19-32.
28. Ranucci M, Ballotta A, Kunkl A, De Benedetti D, Kandil H, Conti D, Mollichelli N, Bossone E, Mehta RH. Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. Am J Cardiol. 2008;101:1112-8.
29. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol. 2004;44:1393-9.
30. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259-64.
31. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, Timmis GC, O'Neill WW. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol. 1999;33:403-11.
32. Hennessy SA, LaPar DJ, Stukenborg GJ, Stone ML, Mlynarek RA, Kern JA, Ailawadi G, Kron IL. Cardiac catheterization within 24 hours of valve surgery is significantly associated with acute renal failure. J Thorac Cardiovasc Surg. 2010;140: 1011-7.
33. Del Duca D, Iqbal S, Rahme E, Goldberg P, de Varennes B. Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg. 2007;84: 1264-71.
34. Ko B, Garcia S, Mithani S, Tholakanahalli V, Adabag S. Risk of acute kidney injury in patients who undergo coronary angiography and cardiac surgery in close succession. Eur Heart J. 2012 Jan 11. [Epub ahead of print].
35. Eltchaninoff H, Prat A, GIlard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Debrux J-L, Tribouilloy C, Pavie A, Gueret P. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-7.
36. Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A. Outcomes After Transcatheter Aortic Valve Implantation With Both Edwards- SAPIEN and CoreValve Devices in a Single Center. JACC Cardiovasc Interv. 2010;3:1110-21.
37. Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Büllesfeld L, Khattab AA, Huber C, Eberle B, Erdös G, Meier B, Jüni P, Carrel T, Windecker S. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011;161:1114-24.
38. Lee P-T, Chou K-J, Liu C-P, Mar G-Y, Chen C-L, Hsu C-Y, Fang H-C, Chung H-M. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coll Cardiol. 2007;50:1015-20.
39. Vogt B, Ferrari P, Schönholzer C, Marti HP, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh-Do U, Uehlinger D, Frey FJ. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med. 2001;111:692-8.
40. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416-20.
41. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180-4.
42. Bove T, Landoni G, Calabrò MG, Aletti G, Marino G, Cerchierini E, Crescenzi G, Zangrillo A. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation. 2005;111:3230-5.
43. Park M, Coca SG, Nigwekar SU, Garg AX, Garwood S, Parikh CR. Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: a systematic review. Am. J. Nephrol. 2010;31:408-18.
44. Patel NN, Rogers CA, Angelini GD, Murphy GJ. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev. 2011;16:553-67.